Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Approval Of The Composite Scheme Of Arrangement Amongst HSB Corporate Consultants Private Limited, Jubilant Stock Holding Private Limited, SSB Consultants & Management Services Private Limited, JCPL Life Science Ventures And Holdings Private Limited, JSPL Life Science Services And Holdings Private Limited, Jubilant Life Sciences Limited And Jubilant Ingrevia Limited And Their Respective Shareholders And Creditors Under Sections 230 To 232 And Other Applicable Provisions Of The Companies Act, 2013.

 We refer to our letter dated December 24, 2020 regarding pronouncement of order by the National Company Law Tribunal ('NCLT'), Allahabad Bench on the captioned matter. We wish to inform you that the Company has today received Formal Order from NCLT. Copy of the said Order is enclosed herewith. We request you to take the same on record.
07-01-2021
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has issued duplicate share certificates as per the attachment. This is for your information and record.
01-01-2021
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Partial Early Redemption Of 4.875% Senior Notes Due 2021 By Jubilant Pharma Limited, Wholly-Owned Subsidiary Of The Company (A Company Incorporated Under The Laws Of Singapore)

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that our material wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) ('JPL') has given notice to the holders of its US$300,000,000 4.875% Senior Notes due 2021 (the 'Notes') that it has elected to exercise its option to redeem US$100,000,000 in aggregate principal amount of the Notes on January 29, 2021 (the 'Redemption Date') pursuant to the terms of the indenture dated as of October 6, 2016 (the 'Indenture') between the Company and The Bank of New York Mellon, London Branch as trustee, governing the Notes. JPL had made the first early redemption of US$100,000,000 in November 2019 and the outstanding amount of the Notes after the proposed redemption of January 29, 2021 would be US$100,000,000. Please refer to the disclosure for further details.
30-12-2020
Bigul

Brokers Call: Jubilant Life (Buy)

 JM FinancialJubilant Life (Buy)Target: 1,030CMP: 866.30As per media reports, Jubilant HollisterStier (Jubilant Life Sciences' arm) has commenced the
24-12-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Closure of Trading Window

 Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for the 'Designated Persons' from Friday, December 25, 2020 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter ending December 31, 2020 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.
24-12-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We wish to inform you that the Hon''ble National Company Law Tribunal, Allahabad Bench ('NCLT') has, by its Order dated December 23, 2020, sanctioned the Composite Scheme of Arrangement under Sections 230 to 232 read with Section 66 and other applicable provisions of the Companies Act, 2013 amongst HSB Corporate Consultants Private Limited, Jubilant Stock Holding Private Limited, SSB Consultants & Management Services Private Limited, JCPL Life Science Ventures and Holdings Private Limited, JSPL Life Science Services and Holdings Private Limited, Jubilant Life Sciences Limited and Jubilant Ingrevia Limited and their respective shareholders and creditors. We enclose herewith copy of the order as available on the website of NCLT. We request you to take the same on record.
24-12-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by Mrs. Alka Gopal Khatri claiming to be the legal heir of the shareholder as per the attachment. Mrs. Alka Gopal Khatri has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the legal heir after verification of the documents received. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
19-12-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be participating in Investec and Motilal conferences on December 15, 16, 17 and 18, 2020. We enclose the details of investor/ analyst meetings scheduled on these dates. The schedule may undergo change due to exigencies on the part of Investors/Analysts/ Company. We also enclose the presentation to be used during the meetings. This is for your kind information and records.
14-12-2020
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be attending the Prabhudas Lilladher Pharma Day through virtual mode on December 3, 2020. We enclose details of the Investor/ Analyst for the same. The schedule may undergo change due to exigencies on the part of Investor/ Analysts/ Company. We also enclose the presentation to be used during the meetings.
02-12-2020

Jubilant Life Sciences raises Rs 90 crore through commercial papers

 New Delhi, Nov 26 Drug firm Jubilant Life Sciences on Thursday said it has issued commercial papers worth Rs 90 crore. Tenure of the instrument i..
26-11-2020
Next Page
Close

Let's Open Free Demat Account